- Aug 31, 2016
- Frostbite Falls, MN
DMT found to prevent recurrence of malignant lung and prostate cancers
Traditional medicinal use of DMT strongly suggests its medical potential. This suggestion is advanced by the discovery that DMT is an endogenous ligand of the sigma-1 receptor. This receptor can influence the energy utilization of cells, and its activation has therapeutic value in many pathological conditions such as ALS, Parkinson’s and cancer.
DMT may play a vital role in immunoregulation. For instance, DMT may help to coordinate the immune responses that fight cancer. This is based on the fact that the molecule's synthesis requires an enzyme called indolethylamine-N-methyltransferase (IMNT), which is produced by the IMNT gene, the expression of which has been found to prevent the recurrence of malignant lung and prostate cancers.
Ede Frecska is Principal Investigator of a group of clinical researchers in Hungary. The group’s main tenet is that the naturally occurring Dimethyltryptamine (DMT) molecule has vital therapeutic and clinical qualities, and is pivotal to the progression of brain science. Their hypothesis is...